A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)

NCT03905330 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Progressive Familial Intrahepatic Cholestasis (PFIC)

Interventions

DRUG: Maralixibat
OTHER: Placebo

Sponsor

Mirum Pharmaceuticals, Inc.